Solarvest BioEnergy

About:

Solarvest has proprietary technology that for the first time enables algae to produce hydrogen in a continuous cycle in a single vessel.

Website: http://solarvest.ca/

Top Investors: Drashta Ventures

Description:

North American and European consumers are becoming more concerned with health: their own health as they (especially baby boomers) age and the health of future generations. As concerns about the impact of pollution on general health and the health of the planet mount, the public in Europe and North America are becoming less and less tolerant of unsustainable practices. Solarvest Inc.’s innovative algae technologies allow for the production of a variety of environmentally sustainable biological products that are a perfect fit with these current market trends/needs. These products include Omega-3 fatty acid oil production for use in human and veterinary nutrition, algae-derived prescription therapeutics and hydrogen generation from algae as a sustainable fuel source. The Company provides a relevant and diverse portfolio with an excellent potential for success for this innovative clean and “green” biologics company. The company was formed in 2006 and since that time has been researching algae culture and expression and primarily investing in natural processes to produce high levels of Omega 3 fatty acids. The company is now ready to begin commercialization of these natural and organic human nutraceutical products.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Charlottetown, Prince Edward Island, Canada

Founded Date:

2006-01-01

Founders:

Gerri Greenham

Number of Employees:

1-10

Last Funding Date:

2017-02-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai